Drug Kinetics – News and Features

Targeted nanoparticles used to deliver proteins, polypeptides and peptides.

Kelly will support Oxyphen's ongoing international expansion.

The MOU provides for Nordic Biotech II K/S or affiliates and co-investors (Nordic) to make an AU$5.2m (US$4.0m) corporate investment in pSivida.

Astech benefits from pharmaceutical technology investment Surge in demand for bespoke automated systems pushes big recruitment drive.

Assays were measured for their reproducibility, signal intensity, and the ability to make genotype calls.

Scientists from Applied Biosystems presented data demonstrating the accuracy of TaqMan® Drug Metabolism Genotyping Assays in identifying variation in genes that code for drug metabolism enzymes.

Steven C. Quay, M.D., Ph.D., Chairman, President and CEO, to present on Thursday, November 9, 2006.

CXR Biosciences and Artemis Pharmaceuticals granted licence to exploit novel transgenic models in drug discovery and development.

Cerno Bioscience announces two major agreements have been reached with leading research institutes in China for the use of its MS data analysis software, MassWorks™.

Accium and CMIC Co. to offer Exploratory-IND (microdosing) and low-radiation PK/ADME clinical trials services to Japan pharmaceutical clients.